Medical News |
- Biomass fuel link to respiratory disease supported
- Psychosocial intervention may benefit youth at risk for bipolar disorder
- Aspirin use in pregnancy may increase risk for childhood psychosis
- Obesity may increase risk for triple-negative breast cancer
- Cardiometabolic triad linked with PAD risk
- Atorvastatin pretreatment ‘fails to improve PCI outcomes’
- Thiazolidinedione use may increase risk for lower respiratory tract infection
- <i>HMGA1</i> variants may increase Type 2 diabetes risk
- Neopterin aids HF risk-prediction in ACS patients
- Glycoprotein IIb/IIIa inhibitors beneficial during elective PCI
| Biomass fuel link to respiratory disease supported Posted: 02 Mar 2011 04:00 PM PST Results from a systematic review and meta-analysis of published studies support a strong association between the regular use of solid biomass fuels and an increased risk for respiratory disease in women and children. |
| Psychosocial intervention may benefit youth at risk for bipolar disorder Posted: 02 Mar 2011 04:00 PM PST Young people at high risk for bipolar disorder may benefit from participating in a family-focused early psychosocial intervention program, say US researchers. |
| Aspirin use in pregnancy may increase risk for childhood psychosis Posted: 02 Mar 2011 04:00 PM PST The maternal use of aspirin during pregnancy is associated with an increased risk for psychotic symptoms in children, research suggests. |
| Obesity may increase risk for triple-negative breast cancer Posted: 01 Mar 2011 04:00 PM PST Data from the Women's Health Initiative study indicate a link between obesity and estrogen receptor positive breast cancer, and also suggest that obese women have an increased risk for triple-negative breast cancer. |
| Cardiometabolic triad linked with PAD risk Posted: 01 Mar 2011 04:00 PM PST A triad of cardiovascular and metabolic factors is strongly linked with the risk for peripheral arterial disease in the French population, study findings suggest. |
| Atorvastatin pretreatment ‘fails to improve PCI outcomes’ Posted: 01 Mar 2011 04:00 PM PST Brief pretreatment with high-dose atorvastatin does not appear to influence peri- or post-procedural outcomes in patients undergoing primary coronary intervention, a randomized trial has found. |
| Thiazolidinedione use may increase risk for lower respiratory tract infection Posted: 01 Mar 2011 04:00 PM PST Patients with Type 2 diabetes who are treated with thiazolidinediones may be at increased risk for pneumonia or other lower respiratory tract infections, suggest results from a systematic review and meta-analysis. |
| <i>HMGA1</i> variants may increase Type 2 diabetes risk Posted: 01 Mar 2011 04:00 PM PST Functional variants in the high-mobility group A1 gene are present in significantly more patients with Type 2 diabetes than nondiabetics, report researchers. |
| Neopterin aids HF risk-prediction in ACS patients Posted: 01 Mar 2011 04:00 PM PST Circulating levels of neopterin, a novel marker of macrophage/ monocyte activation, have prognostic value in patients with heart failure, study findings indicate. |
| Glycoprotein IIb/IIIa inhibitors beneficial during elective PCI Posted: 01 Mar 2011 04:00 PM PST Results from a large meta-analysis indicate that adding a glycoprotein IIb/IIIa inhibitor to aspirin and thienopyridine prior to percutaneous coronary intervention reduces the risk for subsequent nonfatal myocardial infarction. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment